Asthma Awareness Day Capitol Hill
AANMA calls on Congress to address issues that impact the lives of people with asthma, allergies, anaphylaxis and related conditions.
FDA’s Proposed New Paradigm: Techno Medicine Shifts Costs and Risks to Patients
FDA posted a “new paradigm” for public consideration – one in which routine diagnostic and treatment decisions would shift from our physicians to patients and pharmacists and/or other technologies. Read more here.
Deceptive allergy testing practices
New allergy testing and immunotherapy schemes sweeping the country put patients at risk and fleece government and private insurance. How can you ensure quality care for your family?
Sample Asthma Awareness Month Proclaimation
Help us proclaim May 2013 as Asthma Awareness Month across the U.S.! Download this sample to get started and request that the governor of your state or mayor of your city/town issue this proclamation.
Medications at School
Find out if your state protects students’ rights to carry and self-administer prescribed asthma and anaphylaxis medications.
New York State Epinephrine Legislation Needs Your Support!
New York residents: join AANMA in supporting Senate Bill 2210 and Assembly Bill 2566 to permit students to carry and self-administer prescribed epinephrine auto-injectors during the school day.
Congressional Asthma and Allergy Caucus
AANMA supports this bipartisan group of members of Congress dedicated to improving the lives of people with asthma and severe allergies.
NIH Guidelines for the Diagnosis and Management of Asthma
The National Asthma Education and Prevention Program (NAEPP)’s Expert Panel Report #3 (EPR-3) is a comprehensive, evidence-based set of guidelines for healthcare professionals treating asthma.
CHASM — The Consumer Health Alliance for Safe Medication
For questions and to get involved in AANMA’s advocacy efforts, contact Kimberly Turner, Director of Government Affairs, firstname.lastname@example.org or 800.878.4403.